Anti-Mouse CD27 [RM27-3E5] In Vivo Antibody - Low Endotoxin
Introducing the Anti-Mouse CD27 [RM27-3E5] In Vivo Antibody - Low Endotoxin from Assay Genie, a highly specific monoclonal antibody designed for in vivo applications. This antibody targets the CD27 protein, a member of the TNF receptor superfamily, crucial in the regulation of T and B cell activity and immune response, making it ideal for research in immunology and related fields. With a rat IgG2a isotype, it ensures high purity and low endotoxin levels (<1.0 EU/mg), perfect for ELISA, flow cytometry, immunohistochemistry, and other assays.
Available in various sizes, it is formulated in phosphate-buffered saline for stability and efficacy. Enhance your research with this reliable and versatile antibody.
CD27 is a transmembrane protein found on the surface of T cells, B cells, and a subset of natural killer cells. It plays a significant role in the immune system by providing costimulatory signals for T cell activation and survival, particularly through its interaction with its ligand CD70.
Product Name:
Anti-Mouse CD27 (Clone RM27-3E5) In Vivo Antibody - Low Endotoxin
Product Code:
IVMB0331
Size:
1 mg, 5 mg, 25 mg, 50 mg, 100 mg
Clone:
RM27-3E5
Protein:
CD27
Product Type:
Monoclonal Antibody
Synonyms:
CD27, RM27-3E5
Isotype:
IgG2a k
Reactivity:
Mouse
Applications:
FA, FC, In Vivo, IP
Formulation:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Endotoxin Level:
< 1.0 EU/mg as determined by the LAL method
Purity:
≥95% by SDS Page â‹… ≥95% monomer by analytical SEC
Product Preparation:
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Applications:
FA, FC, In Vivo, IP
Reactivity:
Mouse
Host Species:
Rat
Specificity:
RM27-3E5 activity is directed against mouse CD27.
Antigen Distribution:
CD27 is expressed on T cells, B cells, and NK cells.
Immunogen:
Mouse CD27-human IgG1 Fc fusion protein
Concentration:
≥ 5.0 mg/ml
Endotoxin Level:
< 1.0 EU/mg as determined by the LAL method
Formulation:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Purity:
≥95% by SDS Page â‹… ≥95% monomer by analytical SEC
Preparation:
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling:
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
CD27 is a glycosylated, type I transmembrane protein of the TNFR superfamily that is constitutively expressed on the surface of progenitor and naïve T cells as well as subsets of natural killer (NK) and B cells1,2. CD27 is an immune-checkpoint receptor and ligation with CD70 results in co-stimulatory effects that enhance primary, memory, and recall T cell responses. CD27 signaling has been targeted for the development of viral, autoimmune, and anti-tumor immunotherapies2.
RM27-3E5 (rat IgG2a) was raised against recombinant mouse CD27-human IgG1 Fc fusion protein and purified from ascites using protein G columns3,4. RM27-3E5 enhances anti-CD3-stimulated T cell proliferation when immobilized in vitro and augments ovalbumin-specific cytotoxic T lymphocyte (CTL) induction when administered in vivo3.
RM27-3E5 is an agonistic antibody3 and has been found to support the control of both established lung metastases and subcutaneous tumors5. An anti-tumor effect was also observed with RM27-3E5 against EG7/CD27(+) and EG7/CD27(−) tumors4, with the effect mediated mainly by T cells with a minor contribution by NK cells. RM27-3E5 exerts its potent anti-tumor effect by inducing a tumor-specific CTL response. RM27-3E5 has potential utility as a non-depleting agonistic anti-CD27 mAb to enhance anti-tumor immunity4.
